Scientists launch major effort to track rare nerve disease in children
NCT ID NCT04712812
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects health information and biological samples from up to 700 people under 30 with early-onset hereditary spastic paraplegia (HSP). Researchers aim to better understand how the disease progresses over time and create a registry for future studies. Participants provide blood, skin, or saliva samples and complete regular check-ins. No new treatments are tested, but the data will help design future clinical trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AP4-RELATED HEREDITARY SPASTIC PARAPLEGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy aims to halt rare childhood paralysis disorder
- Biggest ALS gene study aims to unlock disease secrets
- New muscle relaxant drug MTR-601 tested in humans for first time
- One Patient's hope: can an old TB drug help a rare paralysis condition?
- Scientists probe tiny muscle changes to help kids with cerebral palsy
- Home exercise program shows promise for rare movement disorder